Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
148
datasets available to search
ShareScore release 0.9.0
Dataset results
148 results for “vemurafenib”
A Pilot Study of Trientine With Vemurafenib for the Treatment BRAF Mutated Metastatic Melanoma
ClinicalTrials.gov study NCT02068079. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Vemurafenib Plus Cobimetinib in Advanced or Metastatic Melanoma Patients
ClinicalTrials.gov study NCT03224208. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Vemurafenib, Carboplatin, and Paclitaxel
ClinicalTrials.gov study NCT01636622. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Vemurafenib With Sorafenib Tosylate or Crizotinib in Treating Patients With Advanced Malignancies With BRAF Mutations
ClinicalTrials.gov study NCT01531361. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety of Tunlametinib Plus Vemurafenib in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT06008119. IPD Sharing: NO. Countries: 1. Publications: 0.
Bioavailability Study of Vemurafenib in Participants With BRAF^V600 Mutation-Positive Malignancies
ClinicalTrials.gov study NCT02441465. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy Study of Vemurafenib and High-dose Interferon Alfa-2b in Melanoma
ClinicalTrials.gov study NCT01943422. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Vemurafenib and Panitumumab Combination Therapy in Patients With BRAF V600E Mutated Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT01791309. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Treatment of a Resistant Disease Using Decitabine Combined With Vemurafenib Plus Cobimetinib
ClinicalTrials.gov study NCT01876641. IPD Sharing: NO. Countries: 1. Publications: 0.
DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers.
ClinicalTrials.gov study NCT05768178. IPD Sharing: YES. Countries: 1. Publications: 0.
Prevention of Phototoxicities in Patients Undergoing Vemurafenib Treatment
ClinicalTrials.gov study NCT03108209. IPD Sharing: NO. Countries: 1. Publications: 0.
Trial of Vemurafenib and Cobimetinib in Patients With Advanced BRAFV600 Mutant Melanoma
ClinicalTrials.gov study NCT02427893. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of the Effect of Vemurafenib on the Pharmacokinetics of Phenprocoumon in Patients With BRAFV600 Mutation-Positive Metastatic Malignancy
ClinicalTrials.gov study NCT01849666. IPD Sharing: Not stated. Countries: 5. Publications: 0.
A Study on the Effect of Vemurafenib on the Pharmacokinetics of a Single Dose of Tizanidine in Patients With BRAFV600 Mutation-Positive Metastatic Malignancies
ClinicalTrials.gov study NCT01844674. IPD Sharing: Not stated. Countries: 5. Publications: 0.
Study of XL888 With Vemurafenib for Patients With Unresectable BRAF Mutated Stage III/IV Melanoma
ClinicalTrials.gov study NCT01657591. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cabozantinib-S-Malate and Vemurafenib in Treating Patients With Solid Tumors or Melanoma That is Metastatic or That Cannot Be Removed By Surgery
ClinicalTrials.gov study NCT01835184. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of The Impact of Severe Hepatic Impairment on the Pharmacokinetics and Safety of Vemurafenib in BRAF V600 Mutation-Positive Cancer Participants
ClinicalTrials.gov study NCT01767623. IPD Sharing: Not stated. Countries: 7. Publications: 0.
Combination or Sequence of Vemurafenib, Cobimetinib, and Atezolizumab in High-risk, Resectable Melanoma
ClinicalTrials.gov study NCT04722575. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Investigate the Effect of Itraconazole and Rifampin on Pharmacokinetics (PK) of Vemurafenib at Steady State
ClinicalTrials.gov study NCT02608034. IPD Sharing: Not stated. Countries: 4. Publications: 0.
A Phase I Trial of Vemurafenib and Hydroxychloroquine in Patients With Advanced BRAF Mutant Melanoma
ClinicalTrials.gov study NCT01897116. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.